Abstract: The present invention relates to cancer diagnostics and therapies and to the detection of alterations in cancer cells that are diagnostic, prognostic or predictive. In particular, the present invention provides a method for detecting and analyzing whether a patient suffering from a cancer is responsive to the treatment with an EGFR inhibitor. In the method, a tissue section from a cancer sample is subjected to assays based on immunohistochemistry and enzymatic metallography.
Type:
Grant
Filed:
March 3, 2011
Date of Patent:
December 17, 2013
Assignees:
Hospital District of Southwest Finland
Inventors:
Olli Carpén, Minnamaija Lintunen, Raija Ristamäki, Jari Sundström, Annika Ålgars
Abstract: The present invention relates to cancer diagnostics and therapies and to the detection of alterations in cancer cells that are diagnostic, prognostic or predictive. In particular, the present invention provides a method for detecting and analyzing whether a patient suffering from a cancer is responsive to the treatment with an EGFR inhibitor. In the method, a tissue section from a cancer sample is subjected to assays based on immunohistochemistry and enzymatic metallography.
Type:
Application
Filed:
March 3, 2011
Publication date:
September 8, 2011
Applicant:
HOSPITAL DISTRICT OF SOUTHWEST FINLAND
Inventors:
Olli CARPEN, Minnamaija LINTUNEN, Raija RISTAMAKI, Jari SUNDSTROM, Annika ALGARS